Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb;42(1):24-28.
doi: 10.18773/austprescr.2019.006. Epub 2019 Feb 1.

The hot patient: acute drug-induced hyperthermia

Nazila Jamshidi  1   2 , Andrew Dawson  1   2
Affiliations
Review

The hot patient: acute drug-induced hyperthermia

Nazila Jamshidi et al. Aust Prescr. 2019 Feb.

Erratum in

Abstract

Drugs can cause dysregulation of the hypothalamic–pituitary–adrenal axis which can result in a rise in core temperature. This type of hyperthermia is unresponsive to antipyretics and can be complicated by rhabdomyolysis, multi-organ failure and disseminated intravascular coagulation

Organic causes of fever such as infection must be ruled out. Syndromes associated with drug-induced fever include neuroleptic malignant syndrome and anticholinergic, sympathomimetic and serotonin toxicity

The class of offending drugs, as well as the temporal relationship to starting or stopping them, assists in differentiating between neuroleptic malignant syndrome and serotonin toxicity

Immediate inpatient management is needed. The mainstay of management is stopping the drug, and supportive care often in the intensive care unit

Keywords: fever; hyperthermia; muscle rigidity; rhabdomyolysis.

PubMed Disclaimer

Conflict of interest statement

Nazila Jamshidi was the editorial registrar for Australian Prescriber in 2018.

References

    1. Hadad E, Weinbroum AA, Ben-Abraham R. Drug-induced hyperthermia and muscle rigidity: a practical approach. Eur J Emerg Med 2003;10:149-54. 10.1097/00063110-200306000-00018 - DOI - PubMed
    1. Eyer F, Zilker T. Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicity. Crit Care 2007;11:236. 10.1186/cc6177 - DOI - PMC - PubMed
    1. O’Grady NP, Barie PS, Bartlett J, Bleck T, Garvey G, Jacobi J, et al. Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med 1998;26:392-408. - PubMed
    1. Caroff SN, Mann SC, Keck PE, Jr. Specific treatment of the neuroleptic malignant syndrome. Biol Psychiatry 1998;44:378-81. - PubMed
    1. Sahin A, Cicek M, Gonenc Cekic O, Gunaydin M, Aykut DS, Tatli O, et al. A retrospective analysis of cases with neuroleptic malignant syndrome and an evaluation of risk factors for mortality. Turk J Emerg Med 2017;17:141-5. 10.1016/j.tjem.2017.10.001 - DOI - PMC - PubMed

LinkOut - more resources